Federal Correspondence and Comment Letters
COVID-19
- Letter to President-elect Biden on COVID-19 pandemic (January 2021)(link opens in new window)(link opens in new window)
- Letter to Congress on COVID-19 Priorities (January 2021)(link opens in new window)(link opens in new window)
- House Dear Colleague Letter - Support Charitable Giving(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)
- Senate Letter for Legacy IRA #GivingTuesdayNow
(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window) - Statement from Nonprofit Organizations in Response to Updated Main Street Lending Program Terms (July 2020)
- Letter to House Members on the Pandemic Child Hunger Prevention Act (August 2020)(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)
- Comments to USDA and HHS on Scientific Report of the 2020 Dietary Guidelines Advisory Committee (August 2020)(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)
- Comments to USDA on Revision of Categorical Eligibility in the Supplemental Nutrition Assistance Program (SNAP) (September 2019)
- Letter to Members of Congress on Farm Bill Priorities (August 2018)
- Letter to House Members on Common Sense Nutrition Disclosure Act (February 2018)
- Comments to FDA on Menu Labeling Supplemental Guidance (January 2018)
- Comments to USDA on Changes to School Meals Nutrition Standards (January 2018)
- Comments to FDA on Proposed Nutrition Facts Label Delay (October 2017)
- Comments to FDA on 1-Year Menu Labeling Delay (August 2017)
- Letter to FDA on Use of Term "Healthy" in the Labeling of Food Products (April 2017)
- Comments to FDA on Long-Term Voluntary Sodium Reduction Targets (December 2016)
- Comments to FDA on Short-Term Voluntary Sodium Reduction Targets (October 2016)
- Letter to Senate Members in Support of S.3136, Improving Child Nutrition Integrity and Access Act (July 2016)
- Letter to FDA Commissioner on Voluntary Standards for Sodium in Food (June 2016)
- Letter to Senate Members on Industry and Public Health Joint Letter Supporting Voluntary Sodium Targets (May 2016)
Tobacco
- Joint Letter to HELP Committee on Tobacco 21 Provisions (June 2019)
- JUUL Marketing Claims of Smoking Cessation (May 2019)
- Joint Letter to Senators McConnell and Kaine in Support of the Tobacco-Free Youth Act (May 2019)
- Joint Letter to Chairman Pallone and Representative Shalala on H.R. 2339 (May 2019)
- Joint Letter to Senator Schatz, Senator Young, Senator Durbin and Senator Romney in Support of the Tobacco to 21 Act (April 2019)
- Joint Letter to Representative Pallone and Representative Stewart in Support of the Tobacco 21 Act (April 2019)
- Joint Letter to Commissioner Gottlieb on the Increased Youth Use of E-Cigarettes (November 2018)
- Comments to FDA on Regulation of Flavors in Tobacco Products (July 2018)
- Joint Comments to HUD on Instituting Smoke-Free Housing Policies (January 2016)
- Partnership to Protect Coverage Recommendations for No Surprises Act (2021)
- Letter of Support from 29 Patient and Consumer Advocacy Organizations for S.J. Res 52 (July 2019)
- Letter of Support from 29 Patient and Consumer Advocacy Organizations for H.J. Res 74 (July 2019)
- Comments to the Office of Management and Budget on Official Poverty Measurement Change (June 2019)
- Letter to Representative Castor in Support of H.R. 1386 (May 2019)
- Letter to Representative Blunt Rochester in Support of H.R. 987 (May 2019)
- Letter to Representative Castor in Support of H.R. 1010 (May 2019)
- 116th Reintroduction Letter on Health Care Principles (May 2019)
- Letter to Representative Kuster in Support of H.R. 986 (May 2019)
- Letter to Chairman Pallone and Ranking Member Walden on Balanced Billing (April 2019)
- Letter to Senator Tillis and other Cosponsors on Pre-Existing Conditions Legislation (September 2019)
- Letter to Farm Bill Conferees on Agriculture Association Health Plans (August 2018)
- Letter to Secretary Azar and Administrator Verma on Navigator Funding Cuts (July 2018)
- Letter to Secretary Azar, Secretary Acosta, and Secretary Mnuchin on Proposed Rule Regarding Short-Term Limited Duration Plans (April 2018)
- Letter Congressional Leadership on Proposed Rule Regarding Short-Term Limited Duration Plans (April 2018)
- Letter to Secretary Azar, Secretary Acosta, and Secretary Mnuchin on Proposed Policy Changes to the Affordable Care Act (March 2018)
- Letter to Congressional Leadership in Opposition to Short-Term Limited Duration Insurance Plans (March 2018)
- Letter to Secretary Azar and Ms. Jane Klinefelter Wilson from Coalition on Association Health Plans (March 2018)
- Letter to Secretary Azar and Ms. Jane Klinefelter Wilson on Association Health Plans (March 2018)
- Joint Comments to USPSTF on Screening for Peripheral Artery Disease (Feb 2018)(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)
- Letter to Acting Secretary Hargan on the Centers for Medicare and Medicaid Services' (CMS) Proposed Rule (November 2017)
- Letter to Senate Majority Leader on Nation's Health Care (August 2017)
- Letter to Senate on Cruz Amendment to Better Care Reconciliation Act of 2017 (July 2017)
- Letter of Support for FAST Act House Sponsors (July 2017)
- Letter to Ohio Gov. John Kasich on American Health Care Reform (June 2017)
- Letter to Senate Finance and HELP Committee to Protect Medicaid Patients (June 2017)
- Letter to Chairman Hatch on American Health Care Reform (May 2017)
- Comments to Senate Finance Committee on Chronic Care Act of 2017 (May 2017)
- Consensus Healthcare Reform Principles (May 2017)
- Letter to House Speaker and House Minority Leader on American Health Care Act (March 2017)
- Letter to Senate Majority Leader and House Speaker on Health Coverage (January 2017)
- Lobby Day "You're the Cure on the Hill" One Pager (2017)
- Supervision of Cardiac and Pulmonary Rehab One Pager (2017)
Public Charge
- Joint Letter to Ms. Syrek Jensen, CMS Director of Coverage and Analysis, on Proposed National Coverage Determination for Ambulatory Blood Pressure Monitoring (July 2019)
- Comments to FDA Commissioner on FDA Action Plan Progress on Demographic Subgroup Data (April 2016)
- Comments to the Senate Finance Committee's Chronic Care Work Group Policy Options Document (January 2016)
Appropriations
